Ames MM - Search Results

1

Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.

Kuffel MJ, Reid JM, Ames MM. Kuffel MJ, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1992;30(1):51-7. doi: 10.1007/BF00686485. Cancer Chemother Pharmacol. 1992. PMID: 1586980

2

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.

Reid JM, Pendergrass TW, Krailo MD, Hammond GD, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Res. 1990 Oct 15;50(20):6525-8. Cancer Res. 1990. PMID: 2208112 Clinical Trial.

3

Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).

Frank SK, Mathiesen DA, Szurszewski M, Kuffel MJ, Ames MM. Frank SK, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1989;23(4):213-8. doi: 10.1007/BF00451644. Cancer Chemother Pharmacol. 1989. PMID: 2924379

4

Preclinical pharmacology of cholera toxin.

Reid JM, Benson JW, Viallet J, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1995;36(2):115-20. doi: 10.1007/BF00689194. Cancer Chemother Pharmacol. 1995. PMID: 7767946

5

Comparative resistance of idarubicin, doxorubicin and their C-13 alcohol metabolites in human MDR1 transfected NIH-3T3 cells.

Kuffel MJ, Ames MM. Kuffel MJ, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1995;36(3):223-6. doi: 10.1007/BF00685850. Cancer Chemother Pharmacol. 1995. PMID: 7781142

6

Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.

Walker DL, Reid JM, Ames MM. Walker DL, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1994;34(4):317-22. doi: 10.1007/BF00686039. Cancer Chemother Pharmacol. 1994. PMID: 8033298

7

Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity.

Reid JM, Walker DL, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1996;38(4):329-34. doi: 10.1007/s002800050491. Cancer Chemother Pharmacol. 1996. PMID: 8674155

8

Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent.

Walker DL, Reid JM, Svingen PA, Rios R, Covey JM, Alley MC, Hollingshead MG, Budihardjo II, Eckdahl S, Boerner SA, Kaufmann SH, Ames MM. Walker DL, et al. Among authors: ames mm. Biochem Pharmacol. 1999 Sep 15;58(6):1057-66. doi: 10.1016/s0006-2952(99)00179-3. Biochem Pharmacol. 1999. PMID: 10509758

9

Murine pharmacokinetics and metabolism of penclomedine [3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine, NSC 338720].

Reid JM, Mathiesen DA, Benson LM, Kuffel MJ, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Res. 1992 May 15;52(10):2830-4. Cancer Res. 1992. PMID: 1581896

10

Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma.

Tefferi A, Witzig TE, Reid JM, Li CY, Ames MM. Tefferi A, et al. Among authors: ames mm. J Clin Oncol. 1994 Mar;12(3):569-74. doi: 10.1200/JCO.1994.12.3.569. J Clin Oncol. 1994. PMID: 8120555 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters